rs6558405

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_201384.3(PLEC):ā€‹c.12813A>Gā€‹(p.Ser4271=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.438 in 1,612,292 control chromosomes in the GnomAD database, including 164,465 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.53 ( 24367 hom., cov: 33)
Exomes š‘“: 0.43 ( 140098 hom. )

Consequence

PLEC
NM_201384.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -3.72
Variant links:
Genes affected
PLEC (HGNC:9069): (plectin) Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 8-143917008-T-C is Benign according to our data. Variant chr8-143917008-T-C is described in ClinVar as [Benign]. Clinvar id is 93030.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-143917008-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.72 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.833 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PLECNM_201384.3 linkuse as main transcriptc.12813A>G p.Ser4271= synonymous_variant 32/32 ENST00000345136.8
PLECNM_201378.4 linkuse as main transcriptc.12771A>G p.Ser4257= synonymous_variant 32/32 ENST00000356346.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PLECENST00000345136.8 linkuse as main transcriptc.12813A>G p.Ser4271= synonymous_variant 32/321 NM_201384.3 Q15149-4
PLECENST00000356346.7 linkuse as main transcriptc.12771A>G p.Ser4257= synonymous_variant 32/321 NM_201378.4 Q15149-9

Frequencies

GnomAD3 genomes
AF:
0.526
AC:
79992
AN:
151958
Hom.:
24329
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.840
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.402
Gnomad ASJ
AF:
0.463
Gnomad EAS
AF:
0.158
Gnomad SAS
AF:
0.364
Gnomad FIN
AF:
0.400
Gnomad MID
AF:
0.415
Gnomad NFE
AF:
0.428
Gnomad OTH
AF:
0.502
GnomAD3 exomes
AF:
0.408
AC:
100154
AN:
245686
Hom.:
22940
AF XY:
0.406
AC XY:
54369
AN XY:
133884
show subpopulations
Gnomad AFR exome
AF:
0.851
Gnomad AMR exome
AF:
0.290
Gnomad ASJ exome
AF:
0.467
Gnomad EAS exome
AF:
0.153
Gnomad SAS exome
AF:
0.363
Gnomad FIN exome
AF:
0.411
Gnomad NFE exome
AF:
0.430
Gnomad OTH exome
AF:
0.429
GnomAD4 exome
AF:
0.429
AC:
626781
AN:
1460216
Hom.:
140098
Cov.:
61
AF XY:
0.426
AC XY:
309242
AN XY:
726336
show subpopulations
Gnomad4 AFR exome
AF:
0.859
Gnomad4 AMR exome
AF:
0.306
Gnomad4 ASJ exome
AF:
0.467
Gnomad4 EAS exome
AF:
0.174
Gnomad4 SAS exome
AF:
0.365
Gnomad4 FIN exome
AF:
0.407
Gnomad4 NFE exome
AF:
0.435
Gnomad4 OTH exome
AF:
0.445
GnomAD4 genome
AF:
0.526
AC:
80068
AN:
152076
Hom.:
24367
Cov.:
33
AF XY:
0.519
AC XY:
38562
AN XY:
74352
show subpopulations
Gnomad4 AFR
AF:
0.840
Gnomad4 AMR
AF:
0.401
Gnomad4 ASJ
AF:
0.463
Gnomad4 EAS
AF:
0.158
Gnomad4 SAS
AF:
0.362
Gnomad4 FIN
AF:
0.400
Gnomad4 NFE
AF:
0.428
Gnomad4 OTH
AF:
0.499
Alfa
AF:
0.468
Hom.:
10309
Bravo
AF:
0.539
Asia WGS
AF:
0.288
AC:
1005
AN:
3478
EpiCase
AF:
0.443
EpiControl
AF:
0.450

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 18, 2013- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 13, 2015p.Ser4408Ser in exon 32 of PLEC: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 43.5% (3608/8294) of European American chromosomes from a broad population by the NHLBI Exome Seq uencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs6558405). -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Epidermolysis bullosa simplex with nail dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Epidermolysis bullosa simplex, Ogna type;C2677349:Epidermolysis bullosa simplex 5C, with pyloric atresia;C2931072:Epidermolysis bullosa simplex 5B, with muscular dystrophy;C3150989:Autosomal recessive limb-girdle muscular dystrophy type 2Q;C4225309:Epidermolysis bullosa simplex with nail dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Epidermolysis bullosa simplex 5C, with pyloric atresia Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Epidermolysis bullosa simplex 5B, with muscular dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Autosomal recessive limb-girdle muscular dystrophy type 2Q Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Epidermolysis bullosa simplex, Ogna type Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.013
DANN
Benign
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6558405; hg19: chr8-144991176; COSMIC: COSV59627110; COSMIC: COSV59627110; API